Aurora Cannabis (ACB) Debt Ratio (2018 - 2026)

Aurora Cannabis (ACB) posted quarterly Debt Ratio of 0.0 for Q1 2026, down 98.99% year-on-year from 0.08 in Q1 2025, and down 96.78% on a QoQ basis from 0.03 in Q4 2025.

Aurora Cannabis (ACB) Debt Ratio (2018 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Debt Ratio for 9 consecutive years, with 0.0 the latest figure, recorded in Q1 2026.

  • Quarterly Debt Ratio fell 98.99% year-over-year to 0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0 (down 98.99% YoY) and the FY2026 annual result came in at 0.0, down 98.99% from the prior year.
  • Debt Ratio fell to 0.0 in Q1 2026 per ACB's latest filing, from 0.03 in the prior quarter.
  • Over the last five years, Debt Ratio for ACB reached as high as 0.26 in Q2 2023 and fell as low as 0.0 in Q1 2022.
  • A 5-year average of 0.1 and a median of 0.07 in 2022 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2022 — Debt Ratio jumped 48280.69% — and 2026, when it plunged 98.99%.
  • Year by year, Debt Ratio stood at 0.07 in 2022, then soared by 176.06% to 0.19 in 2023, then fell by 5.93% to 0.17 in 2024, then tumbled by 85.3% to 0.03 in 2025, then slumped by 96.78% to 0.0 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.03, and 0.03 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 0.26
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 0.42
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 0.60
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 0.29
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 0.10
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.39
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 0.29
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.03
Sep 30, 2025 0.03
Jun 30, 2025 0.06
Mar 31, 2025 0.08
Dec 31, 2024 0.17
Sep 30, 2024 0.17
Jun 30, 2024 0.17
Mar 31, 2024 0.07
Dec 31, 2023 0.19
Sep 30, 2023 0.22
Jun 30, 2023 0.26
Mar 31, 2023 0.06
Dec 31, 2022 0.07
Sep 30, 2022 0.06
Jun 30, 2022 0.01
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00